Considering the antitumoral role of Lp(a), we believe that the elevated Lp(a) levels in high-risk and PSA ≥ 100 PCa patients might be compensatory reactions to chronic inflammation of the whole body caused by aggressiveness and invasion of a tumor. The gene discussed is LPA; the disease is neoplasm.